BDBM37525 2,2,2-trifluoro-N-(2-keto-1,3-dimethyl-benzimidazol-5-yl)acetamide::MLS000070724::N-(1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-2,2,2-trifluoro-acetamide::N-(1,3-dimethyl-2-oxidanylidene-benzimidazol-5-yl)-2,2,2-tris(fluoranyl)ethanamide::N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-2,2,2-trifluoroacetamide::N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)-2,2,2-trifluoroacetamide::SMR000009605::cid_649424

SMILES Cn1c2ccc(NC(=O)C(F)(F)F)cc2n(C)c1=O

InChI Key InChIKey=YJXATMBHASUMTG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 37525   

TargetHuntingtin(Human)
Columbia University Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM37525(N-(1,3-dimethyl-2-oxidanylidene-benzimidazol-5-yl)...)
Affinity DataIC50: 8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/29/2011
Entry Details
PCBioAssay